-
1.发明公开公开(公告)号：US20240304331A1
公开(公告)日：2024-09-12
申请号：US18598428
申请日：2024-03-07
申请人： Kagami Inc. , National Institutes of Biomedical Innovation, Health and Nutrition , Osaka University
发明人： Atsunari Kawashima , Norio Nonomura , Ryoichi Imamura , Akinaru Yamamoto , Tomonori Kimura , Masashi Mita
CPC分类号： G16H50/20 , G01N33/6812 , G01N33/6893 , G01N33/70 , G16H20/10 , G01N2333/76 , G01N2333/8139 , G01N2800/347
摘要： Provided is a method for further improving therapeutic effect and cost efficiency by ascertaining cancer type and treatment responsiveness for individual patients. The invention provides a method which includes providing information regarding cancer type of a subject, comprising assessing the cancer type of the subject using a marker relating to the amount of a D-amino acid in blood of the subject, and providing information relating to the cancer type of the subject, based on the assessment results, as well as a system for providing information pertaining to cancer in a subject, which carries out the method.
-
公开(公告)号：US10550191B2
公开(公告)日：2020-02-04
申请号：US16183216
申请日：2018-11-07
发明人： Tetsuya Yoshida , Yujiro Kidani , Mitsunobu Matsumoto , Takayuki Kanazawa , Satomi Shinonome , Kanji Hojo , Naganari Ohkura , Shimon Sakaguchi , Atsushi Tanaka , Hisashi Wada , Atsunari Kawashima , Norio Nonomura
摘要： The present invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8.
-
公开(公告)号：US20220064312A1
公开(公告)日：2022-03-03
申请号：US17418417
申请日：2019-12-27
发明人： Mai Yoshikawa , Tatsuya Takahashi , Junji Onoda , Sunao Imai , Etsuo Nakamura , Kentaro Furukawa , Tsuguo Miyauchi , Tetsuya Yoshida , Morio Nagira , Naganari Ohkura , Atsushi Tanaka , Shimon Sakaguchi , Hisashi Wada , Atsunari Kawashima
摘要： Disclosed is a novel anti-CCR8 antibody. The antibody can be used for treating or preventing cancers or the like.
-
公开(公告)号：US20200222463A1
公开(公告)日：2020-07-16
申请号：US16732764
申请日：2020-01-02
发明人： Tetsuya Yoshida , Yujiro Kidani , Mitsunobu Matsumoto , Takayuki Kanazawa , Satomi Shinonome , Kanji Hojo , Naganari Ohkura , Shimon Sakaguchi , Atsushi Tanaka , Hisashi Wada , Atsunari Kawashima , Norio Nonomura
摘要： The disclosure provides a pharmaceutical composition with a polypeptide that binds to a peptide produced by cDNA of GenBank ACC No. NM_005201.3 or NM_007720.2, and methods of use thereof.
-
公开(公告)号：US11932696B2
公开(公告)日：2024-03-19
申请号：US17134775
申请日：2020-12-28
发明人： Tetsuya Yoshida , Yujiro Kidani , Mitsunobu Matsumoto , Takayuki Kanazawa , Satomi Shinonome , Kanji Hojo , Naganari Ohkura , Shimon Sakaguchi , Atsushi Tanaka , Hisashi Wada , Atsunari Kawashima , Norio Nonomura
IPC分类号： C07K16/28 , A61K9/00 , A61K35/17 , A61K39/00 , A61K47/60 , A61K47/64 , A61K47/68 , A61P35/00 , G01N33/50
CPC分类号： C07K16/2866 , A61K9/0019 , A61K35/17 , A61K47/60 , A61K47/6435 , A61K47/6883 , A61P35/00 , C07K16/2818 , C07K16/2827 , G01N33/5011 , A61K2039/505 , A61K2039/507 , A61K2039/572 , C07K2317/732 , C07K2317/76
摘要： The present invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8.
-
公开(公告)号：US20210115148A1
公开(公告)日：2021-04-22
申请号：US17134775
申请日：2020-12-28
发明人： Tetsuya Yoshida , Yujiro Kidani , Mitsunobu Matsumoto , Takayuki Kanazawa , Satomi Shinonome , Kanji Hojo , Naganari Ohkura , Shimon Sakaguchi , Atsushi Tanaka , Hisashi Wada , Atsunari Kawashima , Norio Nonomura
IPC分类号： C07K16/28 , A61P35/00 , A61K47/68 , A61K47/60 , A61K47/64 , A61K35/17 , A61K9/00 , G01N33/50
摘要： The present invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8.
-
公开(公告)号：US20210047421A1
公开(公告)日：2021-02-18
申请号：US17085040
申请日：2020-10-30
发明人： Tetsuya Yoshida , Yujiro Kidani , Mitsunobu Matsumoto , Takayuki Kanazawa , Satomi Shinonome , Kanji Hojo , Naganari Ohkura , Shimon Sakaguchi , Atsushi Tanaka , Hisashi Wada , Atsunari Kawashima , Norio Nonomura
IPC分类号： C07K16/28 , A61P35/00 , A61K47/68 , A61K47/60 , A61K47/64 , A61K35/17 , A61K9/00 , G01N33/50
摘要： The present invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8.
-
公开(公告)号：US20200232973A1
公开(公告)日：2020-07-23
申请号：US16732850
申请日：2020-01-02
发明人： Tetsuya Yoshida , Yujiro Kidani , Mitsunobu Matsumoto , Takayuki Kanazawa , Satomi Shinonome , Kanji Hojo , Naganari Ohkura , Shimon Sakaguchi , Atsushi Tanaka , Hisashi Wada , Atsunari Kawashima , Norio Nonomura
摘要： The disclosure provides a method of measuring an efficacy of a drug composition for cancer and a method for treating a cancer by administering to a subject an effective amount of a pharmaceutical composition having a polypeptide that binds to a peptide produced by cDNA of GenBank ACC No. NM_005201.3 or NM_007720.2.
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.058 秒)
